These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9431870)

  • 1. Do calcium-channel blockers and glucocorticoids impair no production in ischaemic heart disease patients?
    Giroux M; Ferrières J; Salles JP
    Int J Cardiol; 1997 Nov; 62(2):171-2. PubMed ID: 9431870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium channel blockers in the treatment of ischemic heart disease].
    Bultas J
    Vnitr Lek; 1995 Mar; 41(3):167-8. PubMed ID: 7762171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calcium channel blocker controversy--caveats for the practitioner and pharmacist.
    Bhagat K
    Cent Afr J Med; 2000 Jun; 46(6):169-70. PubMed ID: 11235061
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study.
    Roberts SJ; Bateman DN
    Br J Clin Pharmacol; 1994 Dec; 38(6):489-97. PubMed ID: 7888286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ischaemic Heart: Beta-Blockade or Calcium Channel Blockade? Proceedings of a satellite symposium at the XIVth Congress of the European Society of Cardiology. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Oct; 14 Suppl F():1-34. PubMed ID: 7903241
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current conception of calcium antagonists use in cardiology. A. L. Miasnikov Research Institute of Cardiology].
    Scientific Society
    Klin Med (Mosk); 1996; 74(4):70-1. PubMed ID: 8999167
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical treatment for silent myocardial ischemia: comparison of nitrate, calcium antagonist, and beta-blocker].
    Tomita F; Kohya T; Kitabatake A
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):516-22. PubMed ID: 12440020
    [No Abstract]   [Full Text] [Related]  

  • 8. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells.
    Ding Y; Vaziri ND
    Hypertension; 1998 Oct; 32(4):718-23. PubMed ID: 9774369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?
    Beevers DG; Sleight P
    BMJ; 1996 May; 312(7039):1143-5. PubMed ID: 8620133
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium antagonists or beta-blockers in chronic ischaemic left ventricular dysfunction?
    Pouleur H
    Eur Heart J; 1993 Oct; 14 Suppl F():26-8. PubMed ID: 7903245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of myocardial ischemia with reference to blood pressure values].
    Schneeweiss A; Wiegand V
    Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of calcium channel blockers in the treatment of cardiovascular diseases.
    Herman ZS
    Pol J Pharmacol; 1999; 51(2):201-6. PubMed ID: 10425650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart rate control: f-channel blockers].
    Kryzhanovskiĭ SA; Vititnova MB
    Fiziol Cheloveka; 2009; 35(2):112-23. PubMed ID: 19402561
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
    Ni Z; Wang XQ; Vaziri ND
    Hypertension; 1998 Oct; 32(4):724-9. PubMed ID: 9774370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A critical evaluation of the therapeutic value of calcium antagonists].
    Metelitsa VI
    Eksp Klin Farmakol; 1996; 59(2):56-61. PubMed ID: 8974569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium channel antagonists and non-cardiac surgery in ischemic cardiopathy].
    Gómez-Arnau J
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(10):407-8. PubMed ID: 9927830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
    Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE
    Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.